News - Almirall

Filter

Current filters:

Almirall

Popular Filters

1 to 25 of 56 results

Spanish pharma companies plan to continue extending their footprint around the world

03-06-2014

Spanish pharmaceutical companies have developed a strong strategy in the last years to expand their products…

AlmirallCinfaEsteve GroupFerrer InternacionalGlobalGrifolsKern PharmaMarkets & MarketingPharmaceuticalPharmaMarSpain

Almirall posts strong 1st-qtr 2014 results

Almirall posts strong 1st-qtr 2014 results

12-05-2014

Spain’s largest pharmaceutical company Almirall this morning reported first-quarter 2014 financial…

AlmirallFinancialPharmaceutical

Almirall gains European rights to InDex Pharma’s Kappaproct

07-04-2014

Sweden’s InDex Pharmaceuticals and Spain’s largest drugmaker Almirall have signed a license agreement…

AlmirallEuropeGastro-intestinalsInDex PharmaceuticalsKappaproctLicensingPharmaceutical

Aqua’s acquisition to push Almirall in US dermatology market

03-04-2014

Spain’s largest drugmaker, Almirall (ALM: MC), announced at the end of last year the acquisition of…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Spanish pharma companies return to sales growth in 2013, after dismal 2012

Spanish pharma companies return to sales growth in 2013, after dismal 2012

04-03-2014

Spanish pharmaceutical companies, reporting their 2013 financial results, have started to see light at…

AlmirallEuropeFaes FarmaFinancialGrifolsPharmaceuticalZeltia

Almirall to acquire US dermatology firm for $305 million upfront

Almirall to acquire US dermatology firm for $305 million upfront

17-12-2013

Spain’s largest drugmaker, Almirall says it has reached a definitive agreement to acquire Aqua Pharmaceuticals,…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Almirall take steps, including cut job, to counter market problems in Europe

05-12-2013

Spain's largest drugmaker Almirall today revealed a reorganization at European level in order to optimize…

AlmirallManagementPharmaceutical

Sativex approved for MS in Switzerland

Sativex approved for MS in Switzerland

27-11-2013

UK-based GW Pharmaceuticals (AIM: GWP), which is focused on novel cannaboid therapeutics, has received…

AlmirallCNS DiseasesEuropeGW PharmaceuticalsPharmaceuticalRegulationSativex

Almirall’s third quarter results boosted by aclidinium sales

Almirall’s third quarter results boosted by aclidinium sales

11-11-2013

Spain's largest drugmaker Almirall (ALM: MC) has released third quarter 2013 financial results reporting…

aclidiniumAlmirallConstellaEuropeFinancialOncologyPharmaceuticalSativex

Aclidinium and formoterol fixed dose combo for COPD filed in Europe by Almirall

04-11-2013

Spain’s largest drugmaker Almirall has filed a Marketing Authorization Application to the European…

aclidiniumAlmirallEuropeformoterolPharmaceuticalRegulationRespiratory and Pulmonary

Agreement reached for Sativex pricing in Germany

25-09-2013

A German unit of Spain’s largest drugmaker Almirall, Hermal GmbH and Germany’s National Association…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

Almirall sets up new affiliate to support Canadian product launches

06-09-2013

Spain's largest pharma company, Almirall (ALM: MC) has continued its expansion with the launch of a new…

AlmirallManagementMarkets & MarketingNorth AmericaPharmaceuticalTudorza Genuair

Forest Labs and Almirall opt to delay US filing for combo COPD drug

15-08-2013

USA-based Forest Laboratories (NYSE: FRX) and Spain's largest drugmaker Almirall (ALM:MC) said late yesterday…

aclidiniumAlmirallForest LaboratoriesformoterolNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTudorza Pressair

IQWiG finds no added benefit proven for Constella in IBS

07-08-2013

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

AlmirallConstellaEuropeGastro-intestinalsIronwood PharmaceuticalsPharmaceuticalPricingRegulation

Almirall first-half sales and earnings decline

29-07-2013

Spain's largest drugmaker Almirall (ALM: MC) reported first-half 2013 results, showing that net revenues…

AlmirallFinancialPharmaceutical

First approved new class of IBS-C therapy, Constella, now available in Europe

13-06-2013

Spain's largest drugmaker Almirall (ALM: MC) and US partner Ironwood Pharmaceuticals, (Nasdaq: IRWD)…

AlmirallConstellaEuropeGastro-intestinalsIronwood PharmaceuticalsMarkets & MarketingPharmaceuticalRegulation

Almirall pays GW Pharma milestone on Sativex; reports 1st-qtr results

07-05-2013

UK-based GW Pharmaceuticals (AIM: GWP) says that it has received commercialization approval for its cannabinoid-based…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Mixed results for Almirall and Forest's LAMA/LABA combo for COPD

02-05-2013

Spain's largest drugmaker Almirall (ALM: MC) and US partner Forest Laboratories (NYSE: FRX) have announced…

aclidiniumAlmirallForest LaboratoriesformoterolPharmaceuticalResearchRespiratory and Pulmonary

Positive Ph III results for Almirall and Forest's combination COPD drug

16-04-2013

Spain's largest pharma company Almirall (ALM: MC) and USA-based partner Forest Laboratories (NYSE:FRX)…

AlmirallBretaris GenuairEklira GenuairForest LaboratoriesPharmaceuticalResearchRespiratory and Pulmonary

Almirall could pull Sativex from German market due to inadequate pricing

20-03-2013

Almirall (ALM: MC), Spain's largest pharma company and the licensee for UK-based GW Pharmaceuticals'…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

The solution for Spanish pharma companies lies abroad

13-03-2013

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain…

AlmirallEuropeFinancialGrifolsPharmaceuticalPricingRegulationZeltia

Added benefit of Almirall's aclidinium bromide is not proven, says Germany's IQWiG

10-01-2013

The drug aclidinium bromide, trade names Eklira, Bretaris from Spain's largest drugmaker Almirall (ALM:…

aclidiniumAlmirallBretaris GenuairEkliraEuropePharmaceuticalPricingRegulationRespiratory and Pulmonary

1 to 25 of 56 results

Back to top